ANZCHOG Children’s Cancer Clinical Trials Repository

Study Title
P3505: Phase I clinical trial of adoptive transfer of multi-virus-specific T cells into TCRaß+/CD19+-depleted haploidentical HSCT recipients
Protocol ID
P3505
Condition/s
Haematological diseases
Diagnosis Stage
New Diagnosis
Relapse/Refractory
Location
QLD, VIC
Sponsor
QIMR Berghofer Medical Research Institute
Trial Status
Open
Sites
Queensland Children's Hospital
Royal Children's Hospital
Study Type
Supportive Care
Phase
Phase 1
Age Eligibility
3 months to 18 years
ANZCTR
ACTRN12620000141943
Back to Registry
Study Title P3505: Phase I clinical trial of adoptive transfer of multi-virus-specific T cells into TCRaß+/CD19+-depleted haploidentical HSCT recipients
Protocol ID P3505
Disease (Sub Disease) Haematological diseases
Diagnosis Stage New Diagnosis
Relapse/Refractory
Location QLD / VIC
Sponsor QIMR Berghofer Medical Research Institute
Links https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=378935&isReview=true
Trial Status Open
Trial Open Date 17/06/2020
Sites Queensland Children's Hospital / Royal Children's Hospital
Study Type Supportive Care
Phase Phase 1
Age Eligibility 3 months to 18 years
ANZCTR ACTRN12620000141943

Join our newsletter

"*" indicates required fields

This field is for validation purposes and should be left unchanged.

Email info@anzchog.org   |  

Level 6, TRF Building, Hudson Institute, 27-31 Wright St, Clayton VIC 3168